Tissue Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
Target | Research Paper | Journal | Product | SKU |
---|---|---|---|---|
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep, 2019 May | Tissue | CR560603 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep, 2019 May | Tissue | CR560671 |
Adenocarcinoma of colon | Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes | Sci Rep, 2019 May | Tissue | CR561163 |
Adenocarcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res., 2019 Dec | Tissue | CP565638 |
Adenocarcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res., 2019 Dec | Tissue | CP565414 |
Adenocarcinoma of ovary | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep., 2020 Mar | Tissue | CP565528 |
Adenocarcinoma of ovary | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep., 2020 Mar | Tissue | CP565532 |
Adenocarcinoma of pancreas | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer | Mol. Cancer, 2019 May | Tissue | CD564012 |
Adenocarcinoma of pancreas | Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer | Mol. Cancer, 2019 May | Tissue | CD563941 |
adenocarcinoma tissue sections | Proteomic Analysis of Temporally Stimulated Ovarian Cancer Cells for Biomarker Discovery | Mol. Cell. Proteomics, Feb 2013; 12: 356 - 368., 2013 Feb | Tissue | CS600781 |
Aneurysm | A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms | Atherosclerosis, 2017 Mar | Tissue | CS801609 |
Aorta | A systematic review investigating the association of microRNAs with human abdominal aortic aneurysms | Atherosclerosis, 2017 Mar | Tissue | CS808048 |
Atherosclerosis | Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction | J Smooth Muscle Res, 2017 Mar | Tissue | CS808380 |
Brain Protein Lysate | Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway | FEBS Lett. 2013 Oct 11. pii: S0014-5793(13)00724-2, 2013 Oct | Tissue | CP565621 |
Brain Protein Lysate | Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway | FEBS Lett. 2013 Oct 11. pii: S0014-5793(13)00724-2, 2013 Oct | Tissue | CP565723 |
Brain Protein Lysate | Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway | FEBS Lett. 2013 Oct 11. pii: S0014-5793(13)00724-2, 2013 Oct | Tissue | CP565732 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv, 2018 May | Tissue | CR560317 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv, 2018 May | Tissue | CR560615 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv, 2018 May | Tissue | CR560023 |
Breast Cancer | A novel histone H4 variant regulates rDNA transcription in breast cancer | bioRxiv, 2018 May | Tissue | CR560116 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS520016 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS537806 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS521057 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS505265 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS555577 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS532986 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS523709 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS607643 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS527811 |
Breast Cancer | Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA | Cell Death Dis, 2018 Feb | Tissue | CS527834 |
Breast Cancer Protein Lysate | IB Kinase Phosphorylates TRAF2 To Promote Mammary Epithelial Cell Transformation | Mol. Cell. Biol., Dec 2012; 32: 4756 - 4768., 2012 Dec | Tissue | CP624650 |
Breast Cancer Tissues | MicroRNA-542-3p Inhibits Tumor Angiogenesis by Targeting Angiopoietin2 | J. Pathol., Jan 2014., 2014 Jan | Tissue | |
Breast Tissue Lysates | Using a cell line breast cancer progression system to identify biomarker candidates | J Proteomics, 2013 Nov | Tissue | |
Breast Tissue Sections | STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors | Nature Medicine 16, 1421-1428 (21 November 2010) doi:10.1038/nm.2250 Article, 2010 Nov | Tissue | |
Breast Tumor Tissue | Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression | Nat. Med., 2014 Mar | Tissue | |
Breast Tumor Tissue FFPE | Broad Cross-Presentation of the Hematopoietically Derived PR1 Antigen on Solid Tumors Leads to Susceptibility to PR1-Targeted Immunotherapy | J. Immunol., Dec 2012; 189: 5476 - 5484., 2012 Dec | Tissue | CS811219 |
Cancer Survey | The antiangiogenic role of the pro-inflammatory cytokine interleukin-31 | Oncotarget, 2017 Mar | Tissue | CT565858 |
Cancer tissue microarrays | Casein Kinase 1{varepsilon} Promotes Cell Proliferation by Regulating mRNA Translation | Cancer Res. Dec 2013., 2013 Dec | Tissue | CT565858 |
Carcinoma of liver | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep., 2020 Mar | Tissue | CP565477 |
Carcinoma of liver | Emerging roles of CCM genes during tumorigenesis with potential application as novel biomarkers across major types of cancers | Oncol. Rep., 2020 Mar | Tissue | CP520741 |
Carcinoma of lung | Dodging COVID-19 Infection: Low Expression and Localization of ACE2 and TMPRSS2 in Human Umbilical Cord-Derived Mesenchymal Stem Cells | Research Square, 2021 Jan | Tissue | CP565586 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res., 2019 Dec | Tissue | CP565643 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res., 2019 Dec | Tissue | CP565586 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res., 2019 Dec | Tissue | CP565564 |
Carcinoma of lung | Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions | Anticancer Res., 2019 Dec | Tissue | CP565534 |
Carcinoma of lung, large cell | Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells | Journal of translational medicine, 2021 Apr | Tissue | CP565586 |
Cardiomyopathy | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep., 2017 Jul | Tissue | CR561340 |
Cardiomyopathy | SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A | Biosci. Rep., 2017 Jul | Tissue | CR562037 |
CD563113 | The DNA methylation landscape of human melanoma | Genomics, 2015 Sep | Tissue | CD563113 |
CD563113 | MIRA-seq for DNA methylation analysis of CpG islands | Epigenomics, 2015 Apr | Tissue | CD563113 |